Skip to content
Vermeulen Lab
 
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
DONATE
×
Vermeulen Lab
 
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
×
Vermeulen Lab
 
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
  • Home
  • People
  • Research
  • News
  • Publications
  • Collaborate
  • Contact
DONATE
×

ERC PoC grant for Louis Vermeulen

  • Posted on January 10, 2019

ERC PoC grant for Louis Vermeulen

Louis Vermeulen received the proof-of-concept grant from the European Research Council. The project aims at development of a nanobody targeting Osteopontin to inhibit the development of colorectal cancer.

A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue.
Previous
The interplay between intrinsic and extrinsic Wnt signaling in controlling intestinal transformation.
Next

CONTACT US

Louis Vermeulen Laboratory​
LEXOR Department, Amsterdam UMC
Cancer Center Amsterdam
Meibergdreef 9
1105 AZ, Amsterdam
The Netherlands
+31 20 56 64824
info@vermeulenlab.org

Our sponsors

kwf
aumc
oncode
amcf
nwo
erc
adhz
mlds
nyscf1
meadc-if

Donate

If you wish to support our research of the molecular cancer subtypes or clonal dynamics in colorectal cancers, please contact the AMC foundation.

amcf